头颈部肿瘤控制概率:复发再程放疗SBRT的剂量-体积效应
美国医学物理学家协会(AAPM)工作组系统综述了SBRT再程放疗局部复发既往照射头颈部癌的剂量-体积与肿瘤控制概率数据,基于8篇文献300余例病例生成剂量-反应模型,提示35-45 Gy(5次)较<30 Gy局部控制更优且可能改善总生存,建议再程治疗采用5次40-50 Gy等效剂量。
要点
- SBRT再程放疗局部复发头颈部癌存在剂量-反应关系。
- 5次35-45 Gy较<30 Gy局部控制更优,可能改善总生存。
- 建议再程治疗采用5次40-50 Gy等效剂量。
核心结论
- SBRT再程放疗局部复发既往照射头颈部癌存在剂量-反应关系,建议采用5次40-50 Gy等效剂量。
研究设计与样本
- AAPM成立工作组,对SBRT治疗局部复发既往照射头颈部癌的剂量/体积与肿瘤控制概率文献进行系统综述,并生成剂量-反应模型。
主要发现
- 8篇文献300余例病例数据显示,5次35-45 Gy较<30 Gy局部控制更优,可能改善总生存。
关键数值与推荐
- 建议再程SBRT采用相当于5次40-50 Gy的剂量。
- 5次35-45 Gy较<30 Gy局部控制更优,可能改善总生存。
临床怎么用
- 局部复发既往照射头颈部癌再程SBRT可考虑5次40-50 Gy等效剂量以优化局部控制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Stereotactic body radiation therapy (SBRT) has emerged as a viable reirradiation strategy for locally recurrent previously-irradiated head and neck cancer. Doses in the literature have varied, which challenges clinical application of SBRT as well as clinical trial design. MATERIAL & METHODS: A working group was formed through the American Association of Physicists in Medicine to study tumor control probabilities for SBRT in head and neck cancer. We herein present a systematic review of the available literature addressing the dose/volume data for tumor control probability with SBRT in patients with locally recurrent previously-irradiated head and neck cancer. Dose-response models are generated that present tumor control probability as a function of dose. RESULTS: Data from more than 300 cases in 8 publications suggest that there is a dose-response relationship, with superior local control and possibly improved overall survival for doses of 35 to 45 Gy (in 5 fractions) compared with <30 Gy. CONCLUSION: Stereotactic body radiation therapy doses equivalent to 5-fraction doses of 40 to 50 Gy are suggested for retreatment.
引用
- Vargo JA, Moiseenko V, Grimm J, et al. Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group. Int J Radiat Oncol Biol Phys. 2018. PMID: 29477291. doi:10.1016/j.ijrobp.2018.01.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。